Literature DB >> 17456916

Type I hypersensitivity to Parthenium hysterophorus in patients with parthenium dermatitis.

Chembolli Lakshmi1, C R Srinivas.   

Abstract

BACKGROUND: Parthenium dermatitis is a major problem in urban and rural India. Patients with severe allergic rhinitis due to exposure to pollens of parthenium are reported to have parthenium specific IgE and IgG antibodies. Parthenium induces contact dermatitis by Type IV hypersensitivity and allergic rhinitis by Type-I hypersensitivity. AIMS: The study was undertaken to detect Type-I and Type-IV hypersensitivity amongst patients with parthenium dermatitis.
METHODS: Fourteen patients with clinical features of parthenium dermatitis who patch tested positive to parthenium were included in the study. Patch testing was done by standard method and results interpreted as recommended by the ICDRG. Serum IgE was determined by chemiluminescence immuno assay system (CLIA). Prick testing was performed and interpreted by standard method.
RESULTS: Twelve out of the 14 patients included, showed a positive prick test. Serum IgE was elevated in all patients to varying degrees (mean IgE-1279.9 IU/ml; N--up to 100 IU/ml).
CONCLUSION: The positive patch test, prick test and elevated serum IgE suggest that both Type-I and Type-IV hypersensitivity may play a role in the induction and perpetuation of parthenium dermatitis in most patients. To date, delayed hypersensitivity was thought to be solely responsible for parthenium dermatitis. This study suggests that a combined type-I and type IV hypersensitivity mechanisms may be operational.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17456916     DOI: 10.4103/0378-6323.31895

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  6 in total

1.  Etiological approach to chronic urticaria.

Authors:  D S Krupa Shankar; Mukesh Ramnane; Eliz Aryal Rajouria
Journal:  Indian J Dermatol       Date:  2010       Impact factor: 1.494

Review 2.  Effects and Management of Parthenium hysterophorus: A Weed of Global Significance.

Authors:  Manpreet Kaur; Neeraj Kumar Aggarwal; Vikas Kumar; Romika Dhiman
Journal:  Int Sch Res Notices       Date:  2014-08-20

3.  Misery of Living with Parthenium Dermatitis: Correlation between Clinical Severity and Quality of Life.

Authors:  Shail Agarwal; Shivani Saini; Ramesh Kumar; Atul Vijay
Journal:  Indian Dermatol Online J       Date:  2021-11-22

4.  Montelukast does not inhibit the late phase reaction in Parthenium dermatitis.

Authors:  Lakshmi Chembolli; C R Srinivas
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

5.  Parthenium the terminator: An update.

Authors:  Chembolli Lakshmi; Cr Srinivas
Journal:  Indian Dermatol Online J       Date:  2012-05

6.  Parthenium dermatitis manifesting clinically as polymorphic light eruption and prurigo nodularis- like lesions with vasculitis-like picture on histopathology.

Authors:  Chembolli Lakshmi; C R Srinivas; Suma B Pillai; S Shanthakumari
Journal:  Indian Dermatol Online J       Date:  2011-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.